Cases & Deals

Maverick Capital completes registered direct offering for $40 million of Common Stock and Warrants by Xenoport

Clients Maverick Capital Ltd.

Jones Day represented funds advised by Maverick Capital Ltd. in connection with a registered direct offering by Xenoport, Inc., a biopharmaceutical company, of $40 million of Common Stock and Warrants.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.